A ECOGRAFIA NO ESTADIAMENTO E SEGUIMENTO DO MELANOMA CUTÂNEO

Joana Cabete, Vasco Serrão, Alexandre João, Stefan Rapprich

Resumo


A ecografia ganhou maior aplicabilidade na Dermatologia com o aparecimento de sondas de maior frequência que possibilitam a visualização de lesões localizadas na pele e tecido celular subcutâneo. A ecografia de alta resolução tem-se desenvolvido particularmente na área do melanoma, onde se tem posicionado não só como exame complementar à vigilância clínica, mas também como método de estadiamento ganglionar. Neste âmbito, a ecografia é mais sensível que a palpação ganglionar, mostra-se superior a outros métodos de imagem no diagnóstico precoce da metastização locoregional e, quando realizada preliminarmente em combinação com a citologia de aspiração por agulha fina, pode diminuir o número de biopsias do gânglio sentinela. Actualmente, os estudos disponíveis sugerem que a ecografia tem um papel relevante na avaliação da doença loco-regional, em particular no doente com melanoma de risco intermédio ou elevado.


Palavras-chave


Melanoma; ultrassonografia; Neoplasias da pele, ultrassonografia; Estadiamento de neoplasias

Texto Completo:

PDF

Referências


Forsea AM, Del Marmol V, de Vries E, Bailey EE, Geller AC. Melanoma incidence and mortality in Europe: new estimates, persistent disparities. Br J Dermatol. 2012;167(5):1124-30.

Arnold M, Holterhues C, Hollestein LM, Coebergh JWW, Nijsten T, Pukkala E, et al. Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015. J Eur Acad Dermatol Venereol. 2014;28(9):1170-78

Baade P, Meng X, Youlden D, Aitken J, Youl P. Time trends and latitudinal differences in melanoma thickness distribution in Australia, 1990–2006. Int J Cancer. 2012; 130(1):170-8.

Simard EP, Ward EM, Siegel R, Jemal A. Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin. 2012; 118-28.

Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, editors. SEER Cancer Statistics Review, 1975-2011. Bethesda: National Cancer Institute. [consultado em 2014, Set 11 ] Disponível em: http://seer.cancer.gov/csr/1975_2011/sections.html.

Gershenwald JE, Thompson W, Mansfield PF, Lee JE, Colome MI, Tseng CH, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol. 1999; 17: 976-83.

Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009; 27:6199-206.

Meier F, Will S, Ellwanger U, Schlagenhauff B, Schittek B, Rassner G, et al. Metastatic pathways and time courses in the orderly progression of cutaneous melanoma. Br J Dermatol. 2002;147(1):62-70.

Fox MC, Lao CD, Schwartz JL, Frohm ML, Bichakjian CK, Johnson TM. Management options for metastatic melanoma in the era of novel therapies: a primer for the practicing dermatologist: part I: Management of stage III disease. J Am Acad Dermatol. 2013; 68(1):1.e1-9.

Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Ding S, Byrd DR, et al. Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micro metastases versus macrometastases. J Clin Oncol. 2010; 28:2452-9.

van der Ploeg AP, van Akkooi AC, Rutkowski P, Nowecki ZI, Michej W, Mitra A, et al. Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria. J Clin Oncol. 2011; 29(16):2206-14.

Fong ZV, Tanabe KK. Comparison of melanoma guidelines in the U.S.A., Canada, Europe, Australia and New Zealand: a critical appraisal and comprehensive review. Br J Dermatol. 2014; 170(1):20-30.

Pflugfelder A, Kochs C, Blum A, Capellaro M, Czeschik C, Dettenborn T, et al. Malignant melanoma S3-guideline “diagnosis, therapy and follow-up of melanoma”. J Dtsch Dermatol Ges. 2013;11 Suppl 6:1-116, 1-126.

Associazione Italiana di Oncoloia Medica. Linee Guida Melanoma.Edizione 2013. [Consultado em 2014, Set 11] Disponível em: http://www.aiom.it/area+pubblica/area+medica/prodotti+scientifici/linee+guida/1,333,1.

Haute Autorité de Santé. Guide – affection de longue durée: Mélanome cutané, Janvier 2012. [Consultado em 2014, Set 11] Disponível em: http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-03/ald_30_guide_melanome_web.pdf

Mandava A, Ravuri PR, Konathan R. High-resolution ultrasound imaging of cutaneous lesions. Indian J Radiol Imaging. 2013; 23(3):269-77.

Kleinerman R, Whang TB, Bard RL, Marmur ES. Ultrasound in dermatology: principles and applications. J Am Acad Dermatol. 2012; 67(3):478-87.

Catalano O, Caracò C, Mozzillo N, Siani A. Locoregional spread of cutaneous melanoma: sonography findings. AJR Am J Roentgenol. 2010; 194(3):735.

Ulrich J, van Akkooi AJ, Eggermont AM, Voit C. New developments in melanoma: utility of ultrasound imaging (initial staging, follow-up and pre-SLNB). Expert Rev Anticancer Ther. 2011; 11(11):1693-701.

Voit C, Mayer T, Kron M, Schoengen A, Sterry W, Weber L, et al. Efficacy of ultrasound B-scan compared with physical examination in follow-up of melanoma patients. Cancer. 2001; 91(12):2409–16.

Blum A, Schlagenhauff B, Stroebel W, Breuninger H, Rassner G, Garbe C. Ultrasound examination of regional lymph nodes significantly improves early detection of locoregional metastases during the follow-up of cutaneous melanoma: results of a prospective study in 1288 patients. Cancer. 2000;88(11):2534-9.

Schmid-Wendtner MH, Paerschke G, Baumert J, Plewig G, Volkenandt M. Value of ultrasonography compared with physical examination for the detection of locoregional metastases in patients with cutaneous melanoma. Melanoma Res. 2003; 13(2):183-8.

Saiag P, Bernard M, Beauchet A, Bafounta ML, Bourgault-Villada I, Chagnon S. Ultrasonography using simple diagnostic criteria vs palpation for the detection of regional lymph node metastases of melanoma. Arch Dermatol. 2005; 141(2):183-9.

Garbe C, Paul A, Kohler-Späth H, Ellwanger U, Stroebel W, Schwarz M, et al. Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy. J Clin Oncol. 2003; 21(3):520-9.

Machet L, Nemeth-Normand F, Giraudeau B, Perrinaud A, Tiguemounine J, Ayoub J, et al. Is ultrasound lymph node examination superior to clinical examination in melanoma follow-up? A monocentre cohort study of 373 patients. Br J Dermatol. 2005; 152(1):66-70.

Solivetti FM, Di Luca Sidozzi A, Pirozzi G, Coscarella G, Brigida R, Eibenshutz L. Sonographic evaluation of clinically occult in-transit and satellite metastases from cutaneous malignant melanoma. Radiol Med. 2006; 111(5):702–8.

Basler GC, Fader DJ, Yahanda A, Sondak VK, Johnson TM. The utility of fine needle aspiration in the diagnosis of melanoma metastatic to lymph nodes. J Am Acad Dermatol. 1997; 36(3 Pt 1):403–8.

Bafounta ML, Beauchet A, Chagnon S, Saiag P. Ultrasonography or palpation for detection of melanoma nodal invasion: a meta-analysis. Lancet Oncol. 2004;5(11):673-80.

Xing Y, Bronstein Y, Ross MI, Askew RL, Lee JE, Gershenwald JE, et al. Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis. J Natl Cancer Inst. 2011; 103(2):129-42.

Forschner A, Eigentler TK, Pflugfelder A, Leiter U, Weide B, Held L, et al.. Melanoma staging: facts and controversies. Clin Dermatol.2010; 28(3):275-80.

Prayer L, Winkelbauer H, Gritzmann N, Winkelbauer F, Helmer M, Pehamberger H. Sonography versus palpation in the detection of regional lymph-node metastases in patients with malignant melanoma. Eur J Cancer. 1990;26(7):827-30.

Tregnaghi A, De-Candia A, Calderone M, Cellini L, Rossi CR, Talenti E, et al. Ultrasonographic evaluation of superficial lymph node metastases in melanoma. Eur J Radiol. 1997; 24(3):216-21.

Blum A, Dill-Müller D. Ultrasound of lymph nodes and the subcutis in dermatology. Hautarzt. 1998; 49(12):942-9.

Schmid-Wendtner MH, Dill-Müller D. Ultrasound technology in dermatology. Semin Cutan Med Surg. 2008; 27(1):44-51.

Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Nieweg OE, Roses DF, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014; 370(7):599-609.

National Comprehensive Cancer Network. Melanoma (Version 4.2014). [Consultado em 2014, Set 11]. Disponível em: http://www.nccn.org/professionals/physician_gls/pdf/melanoma.pdf.

Van Akkooi AC, Verhoef C, Eggermont AM. Importance of tumor load in the sentinel node in melanoma: clinical dilemmas. Nat Rev Clin Oncol. 2010; 7(8):446-54.

Biver-Dalle C, Puzenat E, Puyraveau M, Delroeux D, Boulahdour H, Sheppard F, et al. Sentinel lymph node biopsy in melanoma: our 8-year clinical experience in a single French institute (2002–2009). BMC Dermatol. 2012; 12:21.

Wrightson WR, Wong SL, Edwards MJ, Chao C, Reintgen DS, Ross MI, et al. Complications associated with sentinel lymph node biopsy for melanoma. Ann Surg Oncol. 2003; 10(6):676-80.

Voit CA, Gooskens SL, Siegel P, Schaefer G, Schoengen A, Röwert J, et al. Ultrasound-guided fine needle aspiration cytology as an addendum to sentinel lymph node biopsy can perfect the staging strategy in melanoma patients. Eur J Cancer. 2014; 50(13):2280-8.

Voit C, Kron M, Schäfer G, Schoengen A, Audrig H, Lukowsky A, et al. Ultrasound-guided fine needle aspiration cytology prior to sentinel lymph node biopsy in melanoma patients. Ann Surg Oncol. 2006; 13(12):1682-9.

Catalano O, Siani A. Cutaneous melanoma: role of ultrasound in the assessment of locoregional spread. Curr Probl Diagn Radiol. 2010; 39(1):30-6.

Voit CA, van Akkooi AJ, Schäfer-Hesterberg G, Sterry W, Eggermont AM. Multimodality approach to the sentinel node: an algorithm for the use of presentinel lymph node biopsy ultrasound (after lymphoscintigraphy) in conjunction with presentinel lymph node biopsy fine needle aspiration cytology. Melanoma Res. 2011;21(5):450-6.

Rossi CR, Scagnet B, Vecchiato A, Mocellin S, Pilati P, Foletto M, et al. Sentinel node biopsy and ultrasound scanning in cutaneous melanoma: clinical and technical considerations. Eur J Cancer. 2000; 36(7):895-900.

van Akkooi AC, Voit CA, Verhoef C, Eggermont AM. Potential cost-effectiveness of US-guided FNAC in melanoma patients as a primary procedure and in follow-up. Ann Surg Oncol. 2010; 17(2):660–2.

Dancey AL, Mahon BS, Rayatt SS. A review of diagnostic imaging in melanoma. J Plast Reconstr Aesthet Surg. 2008; 61(11):1275-83.

Voit C, van Akkooi AC, Schäfer-Hesterberg G, Schoengen A, Kowalczyk K, Roewert JC, et al. Ultrasound morphology criteria predict metastatic disease of the sentinel nodes in patients with melanoma. J Clin Oncol. 2010; 28(5):847-52.

van der Ploeg AP, van Akkooi AC, Verhoef C, Eggermont AM. Completion lymph node dissection after a positive sentinel node: no longer a must? Curr Opin Oncol. 2013; 25(2):152-9.

Thomas JM. Prognostic false-positivity of the sentinel node in melanoma. Nat Clin Pract Oncol. 2008; 5(1):18-23.

van Akkooi AC, de Wilt JH, Voit C, Verhoef C, Suciu S, Eggermont AM. Sentinel lymph-node false positivity in melanoma. Nat Clin Pract Oncol. 2008;5(4):E2.

Catalano O, Setola SV, Vallone P, Raso MM, D’Errico AG. Sonography for locoregional staging and follow-up of cutaneous melanoma: how we do it. J Ultrasound Med. 2010; 29(5):791-802.

Blum A, Schmid-Wendtner MH, Mauss-Kiefer V, Eberle JY, Kuchelmeister C, Dill-Müller D. Ultrasound mapping of lymph node and subcutaneous metastases in patients with cutaneous melanoma: results of a prospective multicenter study. Dermatology. 2006;212(1):47-52.

Catalano O, Voit C, Sandomenico F, Mandato Y, Petrillo M, Franco R, et al. Previously reported sonographic

appearances of regional melanoma metastases are not likely due to necrosis. J Ultrasound Med. 2011; 30(8):1041-9.

Saiag P, Bernard M, Beauchet A, Bafounta ML, Bourgault-Villada I, Chagnon S. Ultrasonography using simple diagnostic criteria vs palpation for the detection of regional lymph node metastases of melanoma. Arch Dermatol. 2005; 141(2):183-9.

Machet L, Perrinaud A, Giraudeau B. Routine ultrasonography in melanoma follow-up? Lancet Oncol. 2005;6(1):2.




DOI: http://dx.doi.org/10.29021/spdv.73.1.344

Apontadores

  • Não há apontadores.